Literature DB >> 25256553

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.

Patrizia Borsotti1, Carmen Ghilardi, Paola Ostano, Antonietta Silini, Romina Dossi, Denise Pinessi, Chiara Foglieni, Maria Scatolini, Pedro M Lacal, Raffaele Ferrari, Davide Moscatelli, Fabio Sangalli, Stefania D'Atri, Raffaella Giavazzi, Maria Rosa Bani, Giovanna Chiorino, Giulia Taraboletti.   

Abstract

Differently from most transformed cells, cutaneous melanoma expresses the pleiotropic factor thrombospondin-1 (TSP-1). Herein, we show that TSP-1 (RNA and protein), undetectable in four cultures of melanocytes and a RGP melanoma, was variously present in 13 cell lines from advanced melanomas or metastases. Moreover, microarray analysis of 55 human lesions showed higher TSP-1 expression in primary melanomas and metastases than in common and dysplastic nevi. In a functional enrichment analysis, the expression of TSP-1 correlated with motility-related genes. Accordingly, TSP-1 production was associated with melanoma cell motility in vitro and lung colonization potential in vivo. VEGF/VEGFR-1 and FGF-2, involved in melanoma progression, regulated TSP-1 production. These factors were coexpressed with TSP-1 and correlated negatively with Slug (SNAI2), a cell migration master gene implicated in melanoma metastasis. We conclude that TSP-1 cooperates with FGF-2 and VEGF/VEGFR-1 in determining melanoma invasion and metastasis, as part of a Slug-independent motility program.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FGF-2; Melanoma; Slug; VEGFR-1; cell motility; metastasis; thrombospondin-1

Mesh:

Substances:

Year:  2014        PMID: 25256553     DOI: 10.1111/pcmr.12319

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  21 in total

Review 1.  A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression.

Authors:  Hong-Li Li; Qian-Yu Li; Min-Jie Jin; Chao-Fan Lu; Zhao-Yang Mu; Wei-Yi Xu; Jian Song; Yan Zhang; Sai-Yang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-17       Impact factor: 4.553

2.  Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR.

Authors:  Fuxing Tang; Xiaohong Jiang; Shijie Liao; Yun Liu; Maolin He
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

3.  Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.

Authors:  Albin Jeanne; Camille Boulagnon-Rombi; Jérôme Devy; Louis Théret; Caroline Fichel; Nicole Bouland; Marie-Danièle Diebold; Laurent Martiny; Christophe Schneider; Stéphane Dedieu
Journal:  Clin Exp Metastasis       Date:  2016-06-27       Impact factor: 5.150

4.  Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47.

Authors:  Hiroaki Kamijo; Tomomitsu Miyagaki; Naomi Takahashi-Shishido; Rina Nakajima; Tomonori Oka; Hiraku Suga; Makoto Sugaya; Shinichi Sato
Journal:  Leukemia       Date:  2019-11-11       Impact factor: 11.528

Review 5.  FGFs: crucial factors that regulate tumour initiation and progression.

Authors:  Qian Jing; Yuanyuan Wang; Hao Liu; Xiaowei Deng; Lin Jiang; Rui Liu; Haixing Song; Jingyi Li
Journal:  Cell Prolif       Date:  2016-07-07       Impact factor: 6.831

6.  Thrombospondin-1 might be a therapeutic target to suppress RB cells by regulating the DNA double-strand breaks repair.

Authors:  Pei Chen; Na Yu; Zhang Zhang; Ping Zhang; Ying Yang; Nandan Wu; Lijun Xu; Jing Zhang; Jian Ge; Keming Yu; Jing Zhuang
Journal:  Oncotarget       Date:  2016-02-02

7.  Identifying and targeting determinants of melanoma cellular invasion.

Authors:  Aparna Jayachandran; Prashanth Prithviraj; Pu-Han Lo; Marzena Walkiewicz; Matthew Anaka; Briannyn L Woods; BeeShin Tan; Andreas Behren; Jonathan Cebon; Sonja J McKeown
Journal:  Oncotarget       Date:  2016-07-05

Review 8.  Original insights on thrombospondin-1-related antireceptor strategies in cancer.

Authors:  Albin Jeanne; Christophe Schneider; Laurent Martiny; Stéphane Dedieu
Journal:  Front Pharmacol       Date:  2015-10-29       Impact factor: 5.810

9.  Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1.

Authors:  Bruno Lopes-Bastos; Liang Jin; Fiona Ruge; Sioned Owen; Andrew Sanders; Christopher Cogle; John Chester; Wen G Jiang; Jun Cai
Journal:  Oncotarget       Date:  2017-06-28

10.  Thrombospondin-1 promotes cell migration, invasion and lung metastasis of osteosarcoma through FAK dependent pathway.

Authors:  Chuanzhen Hu; Junxiang Wen; Liangzhi Gong; Xu Chen; Jun Wang; Fangqiong Hu; Qi Zhou; Jing Liang; Li Wei; Yuhui Shen; Weibin Zhang
Journal:  Oncotarget       Date:  2017-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.